Shanghai Golden Leaf Med Tech Co., Ltd.
PrivateLast Round
Series D
Mar 25, 2024
Total Funding Raised
$87.09M
Company Overview
Shanghai Golden Leaf Med Tech Co., Ltd. is a medical device company that develops minimally invasive interventional therapies for chronic diseases such as hypertension, diabetes, and heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Golden Leaf Med Tech Co., Ltd. Comparables
Compare Shanghai Golden Leaf Med Tech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SyMap Medical | 90% | |
| Shanghai Bioxin Biotechnology | 87% | |
| Cortex, Inc. | 82% |
Shanghai Golden Leaf Med Tech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 25, 2024 | ||||
| Series C | Dec 22, 2022 | ||||
| Series B Extension | Apr 6, 2021 | ||||
| Series B | Jul 16, 2019 | ||||
| Series A | Nov 24, 2016 | ||||
Angel | Aug 5, 2013 |
Shanghai Golden Leaf Med Tech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyuan Capital | Series B |
| 新毅投资 | Series C |
| Dingxin Capital | Series D |
| Northern Light Venture Capital | Angel |
| Zhongping Capital | Series D |
| Hengxu Capital | Series C, Series B Extension |
| Jianxing Medical Fund | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2024
$28M round led by Zhongping Capital
- Nov 24, 2016
Raised $3.62M in Series A funding.
Shanghai Golden Leaf Med Tech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Golden Leaf Med Tech Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Golden Leaf Med Tech Co., Ltd. a public or private company?
Shanghai Golden Leaf Med Tech Co., Ltd. is a private company.
What is the current stock price of Shanghai Golden Leaf Med Tech Co., Ltd.?
Shanghai Golden Leaf Med Tech Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Shanghai Golden Leaf Med Tech Co., Ltd. worth (valuation)?
Valuation information for Shanghai Golden Leaf Med Tech Co., Ltd. is not publicly available.
Can I buy Shanghai Golden Leaf Med Tech Co., Ltd. stock?
Shanghai Golden Leaf Med Tech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Golden Leaf Med Tech Co., Ltd.'s last funding round?
Shanghai Golden Leaf Med Tech Co., Ltd.'s most recent funding round was Series D on March 25, 2024.
Who are the main investors in Shanghai Golden Leaf Med Tech Co., Ltd.?
Key investors in Shanghai Golden Leaf Med Tech Co., Ltd. include Northern Light Venture Capital, Zhongping Capital, Jianxing Medical Fund, Kuanping Capital.
Will Shanghai Golden Leaf Med Tech Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Golden Leaf Med Tech Co., Ltd..
How can I track Shanghai Golden Leaf Med Tech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Golden Leaf Med Tech Co., Ltd.'s secondary market activity and sign up for updates.